Skip to main navigation
  • About
    • Leadership
    • Board of Directors
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
    • Partnerships
  • Investors
  • Careers
  • News
  • Contact Us
F-star Therapeutics
  • Careers
  • Investors
  • About
    • Leadership
    • Board of Directors
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
  • Contact

Events & Presentations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
  • SEC Filings
  • Analyst Coverage
  • Annual Shareholder Meeting
  • Governance
  • IR Resources
  • Navigate
      • Overview
      • Press Releases
      • Events & Presentations
      • Stock Information
      • SEC Filings
      • Analyst Coverage
      • Annual Shareholder Meeting
      • Governance
      • IR Resources

Upcoming Events

  • Dec 6, 2022

    F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress
    View Poster 1.5 MB
lab

Corporate Presentation

Download

Past Events

  • Sep 13, 2021 at 7:00 AM EDT

    H.C. Wainwright Annual Global Investment Conference
    Listen to webcast
  • Aug 12, 2021 at 9:00 AM EDT

    F-Star Therapeutics Second Quarter 2021 Earnings Call
    Listen to webcast
    View Presentation 6.4 MB
  • Jul 14, 2021 at 11:20 AM EDT

    William Blair Biotech Focus Conference 2021
  • Jul 13, 2021 at 9:30 AM EDT

    Ladenburg Thalmann Healthcare Conference 2021
    Listen to webcast
  • May 17, 2021 at 9:00 AM EDT

    F-Star Therapeutics First Quarter 2021 Earnings Call
    Listen to webcast
    View Presentation 6.3 MB
  • Mar 30, 2021

    GrowthCap Interview with CEO, Eliot Forster, Ph.D
    Listen to interview
  • Mar 29, 2021 at 9:00 AM EDT

    F-Star Therapeutics Fourth Quarter 2020 Earnings Call
    Listen to webcast
    View Presentation 544.9 KB
  • Mar 17, 2021 at 8:00 AM EDT

    Oppenheimer & Co 31st Annual Healthcare Conference
    Listen to webcast
  • Mar 9, 2021 at 7:00 AM EST

    H.C. Wainwright Global Life Science Conference
  • Jan 20, 2021 at 11:30 AM EST

    B Riley Oncology Investor Conference
    Listen to webcast

Pagination

  • Previous page < Previous
  • Page 1
  • Current page 2
  • Page 3
  • Next page Next >
  • Investor Contact
  • RSS
  • Print Page

About

  • Overview
  • Leadership
  • Board of Directors
  • Pharmaceutical Partnerships

Technology

  • Overview
  • Our Platform
  • Publications
  • Intellectual Property

Pipeline

  • Program Overview
  • FS118
  • FS120
  • FS222
  • SB 11285

 

  • Investors
  • Careers
  • News
  • Contact Us
  • About
    • Leadership
    • Board of Directors
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
    • Partnerships
  • Investors
  • Careers
  • News
  • Contact Us
  • LinkedIn
  • Twitter

Eddeva B920
Babraham Research
CampusCambridge, CB22 3AT, UK

245 First Street
Riverview II, Floor 18
Cambridge, MA 02142, USA

  • Disclaimer
  • Privacy Policy
  • Cookie Policy
  • Careers
  • Sitemap

© 2023 F-star Therapeutics, Inc.